217 results on '"Pellat, Anna"'
Search Results
2. Comment on “How Does Omitting Additional Surgery After Local Excision Affect the Prognostic Outcome of Patients With High-Risk T1 Colorectal Cancer?”
3. Preferred study designs to support a comparative therapeutic strategy question in oncology: a vignette study
4. Tumeurs neuroendocrines digestives bien différenciées: focus sur les tumeurs pancréatiques
5. Endoscopic submucosal dissection versus endoscopic mucosal resection for early esophageal adenocarcinoma
6. Predictive factors of radiofrequency ablation failure in the treatment of dysplastic Barrett's esophagus
7. Artificial intelligence: A review of current applications in hepatocellular carcinoma imaging
8. Follow-up after endoscopic resection for early gastric cancer in 3 French referral centers
9. First-line chemotherapy with raltitrexed in metastatic colorectal cancer: an Association des Gastro-entérologues Oncologues (AGEO) multicentre study
10. Assessment of transparency and selective reporting of interventional trials studying colorectal cancer
11. Outcomes of endoscopic mucosal resection for large superficial non-ampullary duodenal adenomas
12. Measuring and correcting staff variability in large-scale OSCEs.
13. Peptide receptor radionuclide therapy: How to optimized its efficacy?
14. Highlights in digestive neuroendocrine neoplasms from the GTE 2023
15. Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study.
16. Cinematic Rendering of Gastrointestinal Stromal Tumours: A Review of Current Possibilities and Future Developments.
17. Fusions NTRK : une nouvelle piste dans les cancers digestifs ?
18. Comprehensive preoperative assessment of ileal neuroendocrine tumor with cinematic rendering
19. Esophageal squamous cell carcinoma: from screening to endoscopic resection
20. A preoperative computed tomography radiomics model to predict disease-free survival in patients with pancreatic neuroendocrine tumors
21. Syndrome de Lynch : quoi de neuf ?
22. Immunotherapy and metastatic colorectal cancers with microsatellite instability or mismatch repair deficiency
23. Temps forts du GTE 2023 sur les néoplasies neuro-endocrines digestives.
24. La radiothérapie interne vectorisée : Comment optimiser son efficacité ?
25. CT and MRI of Gastrointestinal Stromal Tumors: New Trends and Perspectives.
26. Polypes festonnés et polypose festonnée : ce que tout hépato-gastro-entérologue doit savoir.
27. Diagnostic Yield of Repeat Endoscopic Ultrasound-Guided Fine Needle Biopsy for Solid Pancreatic Lesions
28. Carcinome épidermoïde superficiel de l'œsophage : du dépistage au traitement endoscopique.
29. Impact of Sarcopenia on Survival in Patients Treated with FOLFIRINOX in a First-Line Setting for Metastatic Pancreatic Carcinoma
30. Airborne transmission of SARS‐Cov2: What consequences for digestive endoscopy?
31. Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world setting
32. Mechanisms of esophageal stricture after extensive endoscopic resection: a transcriptomic analysis
33. Impact of Sarcopenia on Patients with Localized Pancreatic Ductal Adenocarcinoma Receiving FOLFIRINOX or Gemcitabine as Adjuvant Chemotherapy
34. A new system to prevent SARS-CoV-2 and microorganism air transmission through the air circulation system of endoscopes
35. Tumor microenvironment: A new application for radiomics
36. BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment?
37. eOSCE stations live versus remote evaluation and scores variability
38. Imaging of Pancreatic Ductal Adenocarcinoma: An Update on Recent Advances
39. Levels of Evidence Supporting United States Guidelines in Pancreatic Adenocarcinoma Treatment
40. Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years
41. The Safety of Long-Term Proton Pump Inhibitor Use on Cardiovascular Health: A Meta-Analysis
42. Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology
43. Durvalumab (D) plus tremelimumab (T) immunotherapy in patients (Pts) with advanced biliary tract carcinoma (BTC) after failure of platinum-based chemotherapy (CTx): Interim results of the IMMUNOBIL GERCOR D18-1 PRODIGE-57 study.
44. Therapeutic Management of Advanced Hepatocellular Carcinoma: An Updated Review
45. Endoscopic ultrasound guided fine needle biopsy in patients with suspected gastric linitis plastica
46. Availability of results of interventional studies assessing colorectal cancer from 2013 to 2020
47. Additional file 1 of Assessment of transparency and selective reporting of interventional trials studying colorectal cancer
48. Additional file 3 of Assessment of transparency and selective reporting of interventional trials studying colorectal cancer
49. Additional file 2 of Assessment of transparency and selective reporting of interventional trials studying colorectal cancer
50. Outcomes of Endoscopic Mucosal Resection for Large Superficial Non-Ampullary Duodenal Adenomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.